RARX
UBS AM’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-41,067
| Closed | -$1.97M | – | 2594 |
|
|
2020
Q1 | $1.97M | Sell |
41,067
-159,993
| -80% | -$7.68M | ﹤0.01% | 1415 |
|
|
2019
Q4 | $9.44M | Sell |
201,060
-113,397
| -36% | -$5.32M | 0.01% | 963 |
|
|
2019
Q3 | $7.44M | Sell |
314,457
-3,853
| -1% | -$91.1K | 0.01% | 1058 |
|
|
2019
Q2 | $9.57M | Buy |
318,310
+3,478
| +1% | +$105K | 0.01% | 976 |
|
|
2019
Q1 | $7.05M | Buy |
+314,832
| New | +$7.05M | 0.01% | 1035 |
|
|
2018
Q2 | – | Sell |
-20,300
| Closed | -$108K | – | 2820 |
|
|
2018
Q1 | $108K | Buy |
+20,300
| New | +$108K | ﹤0.01% | 2452 |
|